Advertisement

Table of Contents

July 01, 1989; Volume 36,Issue 1

You have access
Evidence for a pulmonary B3 bradykinin receptor.
S G Farmer, R M Burch, S A Meeker and D E Wilkins

Molecular Pharmacology July 1989, 36 (1) 1-8;
You have access
Cellular pharmacology of 3'-azido-3'-deoxythymidine with evidence of incorporation into DNA of human bone marrow cells.
J P Sommadossi, R Carlisle and Z Zhou

Molecular Pharmacology July 1989, 36 (1) 9-14;
You have access
Identification of the ligand-binding subunit of the human 5-hydroxytryptamine1A receptor with N-(p-azido-m-[125I] iodophenethyl)spiperone, a high affinity radioiodinated photoaffinity probe.
J R Raymond, A Fargin, M J Lohse, J W Regan, S E Senogles, R J Lefkowitz and M G Caron

Molecular Pharmacology July 1989, 36 (1) 15-21;
You have access
Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
J A Moscow, A J Townsend and K H Cowan

Molecular Pharmacology July 1989, 36 (1) 22-28;
You have access
Immunological characterization of human phenol sulfotransferase.
J A Heroux, C N Falany and J A Roth

Molecular Pharmacology July 1989, 36 (1) 29-33;
You have access
Development of a photoaffinity ligand for octopamine receptors.
J A Nathanson

Molecular Pharmacology July 1989, 36 (1) 34-43;
You have access
Calcium-dependent effects of maitotoxin on phosphoinositide breakdown and on cyclic AMP accumulation in PC12 and NCB-20 cells.
F Gusovsky, T Yasumoto and J W Daly

Molecular Pharmacology July 1989, 36 (1) 44-53;
You have access
Characterization and quantitation of monoamine oxidases A and B in mitochondria from human placenta.
L A Riley, M A Waguespack and R M Denney

Molecular Pharmacology July 1989, 36 (1) 54-60;
You have access
Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes.
T D Porter, S C Khani and M J Coon

Molecular Pharmacology July 1989, 36 (1) 61-65;
You have access
The human cytochrome Cyp1A2 gene contains regulatory elements responsive to 3-methylcholanthrene.
L C Quattrochi and R H Tukey

Molecular Pharmacology July 1989, 36 (1) 66-71;
You have access
Selective parasympathectomy increases the quantity of inhibitory guanine nucleotide-binding proteins in canine cardiac ventricle.
T D Hodges, J C Bailey, J W Fleming and R J Kovacs

Molecular Pharmacology July 1989, 36 (1) 72-77;
You have access
Podophyllotoxin analogs: effects on DNA topoisomerase II, tubulin polymerization, human tumor KB cells, and their VP-16-resistant variants.
S Y Liu, B D Hwang, M Haruna, Y Imakura, K H Lee and Y C Cheng

Molecular Pharmacology July 1989, 36 (1) 78-82;
You have access
Human NADPH-P450 oxidoreductase: complementary DNA cloning, sequence and vaccinia virus-mediated expression and localization of the CYPOR gene to chromosome 7.
S Yamano, T Aoyama, O W McBride, J P Hardwick, H V Gelboin and F J Gonzalez

Molecular Pharmacology July 1989, 36 (1) 83-88;
You have access
Oxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
T Kronbach, D Mathys, M Umeno, F J Gonzalez and U A Meyer

Molecular Pharmacology July 1989, 36 (1) 89-96;
You have access
Identification of a polymorphically expressed member of the human cytochrome P-450III family.
S A Wrighton, B J Ring, P B Watkins and M VandenBranden

Molecular Pharmacology July 1989, 36 (1) 97-105;
You have access
Delayed increase of Ca2+ influx elicited by glutamate: role in neuronal death.
H Manev, M Favaron, A Guidotti and E Costa

Molecular Pharmacology July 1989, 36 (1) 106-112;
You have access
[125I]2-iodo-3,7,8-trichlorodibenzo-p-dioxin-binding species in mouse liver induced by agonists for the Ah receptor: characterization and identification.
A Poland, P Teitelbaum and E Glover

Molecular Pharmacology July 1989, 36 (1) 113-120;
You have access
Stimulation of in vivo hepatic uptake and in vitro hepatic binding of [125I]2-lodo-3,7,8-trichlorodibenzo-p-dioxin by the administration of agonist for the Ah receptor.
A Poland, P Teitelbaum, E Glover and A Kende

Molecular Pharmacology July 1989, 36 (1) 121-127;
You have access
Molecular mechanism of 7,12-dimethylbenz[a]anthracene-induced immunosuppression: evidence for action via the interleukin-2 pathway.
M J Pallardy, R V House and J H Dean

Molecular Pharmacology July 1989, 36 (1) 128-133;
You have access
Interaction of [3H]dilazep at nucleoside transporter-associated binding sites on S49 mouse lymphoma cells.
W P Gati and A R Paterson

Molecular Pharmacology July 1989, 36 (1) 134-141;
You have access
Thrombin and trypsin act at the same site to stimulate phosphoinositide hydrolysis and calcium mobilization.
L G Jones, P M McDonough and J H Brown

Molecular Pharmacology July 1989, 36 (1) 142-149;
You have access
Class I antiarrhythmic drug receptor: biochemical evidence for state-dependent interaction with quinidine and lidocaine.
R J Hill, H J Duff and R S Sheldon

Molecular Pharmacology July 1989, 36 (1) 150-159;
You have access
Tricyclic antidepressants and dextromethorphan bind with higher affinity to the phencyclidine receptor in the absence of magnesium and L-glutamate.
M A Sills and P S Loo

Molecular Pharmacology July 1989, 36 (1) 160-165;
You have access
Glycogen phosphorylase activation by two different alpha 1-adrenergic receptor subtypes: methoxamine selectively stimulates a putative alpha 1-adrenergic receptor subtype (alpha 1a) that couples with Ca2+ influx.
G Tsujimoto, A Tsujimoto, E Suzuki and K Hashimoto

Molecular Pharmacology July 1989, 36 (1) 166-176;
You have access
Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors.
C E Spivak, J A Waters and R S Aronstam

Molecular Pharmacology July 1989, 36 (1) 177-184;
You have access
Permeation and salvage of dideoxyadenosine in mammalian cells.
P G Plagemann and C Woffendin

Molecular Pharmacology July 1989, 36 (1) 185-192;
You have access
Dissociation of the accumulation of single-strand breaks in DNA from the killing of cultured hepatocytes by an oxidative stress.
J B Coleman, D Gilfor and J L Farber

Molecular Pharmacology July 1989, 36 (1) 193-200;
You have access
Comparison of two putatively selective radioligands for labeling central nervous system beta-adrenergic receptors: inadequacy of [3H]dihydroalprenolol.
M A Riva and I Creese

Molecular Pharmacology July 1989, 36 (1) 201-210;
You have access
Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
M A Riva and I Creese

Molecular Pharmacology July 1989, 36 (1) 211-218;